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Abstract The var-gene encoding Plasmodium falciparum
erythrocyte membrane protein 1 (PfEMP1) is known to
play a major role in the pathogenicity of the P. falciparum
parasite. The protein enables the parasite to adhere to the
endothelial linings of small blood vessels (cytoadherence)
as well as to non-infected erythrocytes (rosetting), thus
preventing clearance from the bloodstream. The develop-
ment and spread of resistance towards most anti-malarial
drugs used for treatment and prevention of the most severe
form of malaria truly emphasise the importance of a
continuous research and development of new drugs. In this
study we use Systematic Evolution of Ligands by EXpo-
nential enrichment (SELEX) methodology to isolate high-
affinity ligands (aptamers). To validate the results from the
SELEX in vitro selection, different aptamers have been
selected against PfEMP1 in a live cell assay of
P. falciparum strain FCR3S1.2, a highly rosetting strain.
We have been able to show the rosette disrupting capacity
of these SELEX-aptamers at concentrations of 33 nM and
with 100% disruption at 387 nM. The described results
show that RNA aptamers are promising candidates for
adjunct therapy in severe malaria.
Introduction
Plasmodium falciparum is the causative agent of severe
malaria in humans. Millions of people worldwide are
infected every year by P. falciparum and more than one
million die, most of them small children in sub-Saharan
Africa (Skeet 2005). Quinine, chloroquine and sulfadoxine/
pyrimethamine (SP) is the most common malaria drugs but
unfortunately parasite resistance towards all these drugs has
been documented in endemic regions (White 1998). The
most efficient drug used today is artemisinin and its
derivates and although no clinical resistance has been
demonstrated, there are indications of a developed in vitro
resistance towards the drug in P. falciparum (Ashley and
White 2005). Therefore there is a need to discover new
drugs or alternative ways to fight the disease. One strategy
would be to hinder the infected red blood cells from
adhering to the endothelial linings of small blood vessels
(cytoadherence) or to uninfected erythrocytes (rosetting),
which should increase parasitic clearance from the blood-
stream by the spleen (Ho and White 1999; Chen 2007).
Cytoadherence and rosetting is linked to P. falciparum
erythrocyte membrane protein 1 (PfEMP1), a protein
expressed in the infected erythrocyte (Baruch et al. 1995;
Chen et al. 2000). Exposed on the surface of the infected
erythrocyte it binds to a number of human cell surface
receptors such as heparan sulphate (HS), ICAM-1, CD36
and CSA (Chen 2007). PfEMP1 consist mainly of duffy-
binding ligand domains (DBLs) and cysteine rich inter
domain regions, and the number of domains and size of the
protein varies depending on which of the 60 var-genes is
expressed (Flick and Chen 2004). The parasite expresses a
single var-gene giving rise to one specific PfEMP1 protein.
By switching to another var-gene and hence another
PfEMP1, antigenic variation of the infected erythrocyte
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host immune system. Structural conservation is expected
due to the adhesive function of this protein irrespective of
the isoform expressed. Rosetting, the virulence associated
phenotype, is mediated by the N-terminal duffy-binding-
like domain (DBL1α) which has a degree of sequence
conservation relative to other PfEMP1 domains and the one
domain that is present in almost all the different PfEMP1s
(Normark et al. 2007). This makes DBL1α an attractive
candidate for the development of a novel drug against
severe malaria or as a vaccine candidate; however, antibody
recognition of the structural semi-conserved epitopes in
DBL1α have shown limited cross-reactivity between
different P. falciparum strains (Ahuja et al. 2006). Due to
the smaller size of aptamers compared to antibodies they
have a potential to reach more buried conserved regions of
the protein, and bind its target with high affinity. In some
reported cases even with higher specificity than antibodies
(Kusser 2000; Stoltenburg et al. 2007). Based on these
characteristics we designed a Systematic Evolution of
Ligands by EXponential enrichment (SELEX) protocol
(Ellington and Szostak 1990; Tuerk and Gold 1990) which
could be designed to allow the selection of serum-stable
RNA aptamers to bind with specificity to the structurally
conserved parts of DBL1α. A similar strategy has been
reported for other pathogenic parasites where aptamers
have successfully been selected against surface proteins
(Ulrich et al. 2002; Lorger et al. 2003). The SELEX method
is based on an iterative process of in vitro selection cycles
where the initial DNA/RNA library of 10
14–10
15 different
molecules is reduced to a smaller pool of different
molecules that have affinity towards the target in question.
We also investigated whether specific affinity binding
aptamers were able to bind to PfEMP1 on the surface of
live parasites and whether they had the capacity to disrupt
rosettes. We demonstrate a set of aptamers that can inhibit
the formation of rosettes.
Material and methods
Culturing of P. falciparum Blood stage parasites of
P. falciparum strain FCR3S1.2 was cultivated according
to standard methods with 10% AB
+Rh
+ serum added to
buffered medium (Flick et al. 2004)
Protein expression in Escherichia coli Recombinant
DBL1α
His from FCR3S1.2 was expressed as follows,
SG13009 (pREP4) cells from Qiagen harbouring plasmids
pQE-TriSystem His·Strep 2( D B L 1 α
his), or pQE-60
(DBL1α
his) (Moll et al. 2007) were grown in LB-medium
containing ampicillin (100µg/ml) and kanamycin (30µg/ml)
at either 22°C or 37°C. At OD600=0.8 cells were induced
with 0.1 mM IPTG for 3 h; 1 l cell suspension was
harvested. Pellet was resuspended in 25 ml lysis buffer
(50 mM NaH2PO4/NaOH pH7.4, 300 mM NaCl, 1 mM
PMSF, 0.05% Triton x-100, 10 mM imidazole). Cells were
incubated with Lysozyme (Sigma) on ice for 30 min, and
sonicated. Cell debris was removed by centrifugation (4°C,
30 min, 18,000×g). Supernatant was treated with DNAse
(Fermentas) and protein was purified according to manufac-
turer (Qiagen). Elution was dialysed in phosphate-buffered
saline (PBS) overnight at 4°C in dialysis tube with 8,000
molecular weight cut-off (Gentaur). Protein purity was
estimated by running samples on 10% SDS-PAGE and
protein concentration was determined by Bradford assay
(Bradford 1976). Alternatively, His-tagged DBL1α was
purified on FPLC. E. coli extracted soluble fraction was
loaded onto nickel column on FPLC (Amersham Bioscien-
ces) with a flow speed of 0.5 ml/min. Bound protein was
washed with 5–70 mM imidazole gradient (60 ml at
1 ml/min). Protein was eluted with 400 mM imidazole and
dialysed and analysed as previously described. A fusion
protein of glutathione S-transferase (GST) and DBL1α was
expressed from a previously cloned pGEX-4 T1 vector in
E. coli (Flick et al. 2004).
In vitro selection—SELEX The DNA library was generated
using oligo B (5′-CGACTGCAGAGCTTGCTACG (N)50
GGTACCGAGCTCGAATTCCC-3′) and oligo A
(5′-GCGTAATACGACTCACTATAGGGAATT
CGAGCTCGGTACC-3′), sequence for T7 promoter under-
lined. Oligonucleotides were synthesised and purchased
from IBA, Germany. Oligo B contains a central sequence
(N)50 of 50 randomised nucleotides flanked by constant
regions. Double-stranded DNA Library was created by
annealing 3µM of Oligo A and Oligo B (95°C for 5 min
and cool for 15 min at 25°C), subsequently adding Klenow
fragment (Fermentas) in the supplied buffer at 37°C for 2 h,
purified by Microcon Ym-30 column (Millipore) and eluted
in 30µl RNAse-free water. 2′F-modified library was created
by T7 RNA transcription of 40µg template using T7
R&DNA™ Polymerase (Epicentre) in supplied transcrip-
tion buffer adding DTT (Epicentre) to 10 mM and ATP,
GTP, 2′F-dCTP, 2′F-dUTP (Epicentre) to 1.25 mM. RNA
was labelled by adding 0.37 MBq [α-
32P]-ATP (Amersham
Biosciences) in 20-µl reaction volume. Reaction ran at
37°C for 5 h and DNA/RNA was precipitated using 0.2 M
NaOAc (pH=5.2), 70% EtOH. Sample ran on 10% 8 M
UREA PAGE and RNA was exercised and extracted from
the gel with 1 M NaOAc (pH=4.7) overnight at 4°C. After
centrifugation with glass wool RNA was precipitated with
70% EtOH and glycogen to 0.05%. The first selection cycle
was performed with 30µg (1 nmol) radioactive labelled 2′
F-RNA and a minimum of 60µg (1.3 nmol) purified
DBL1α. Subsequent cycles were performed with 300 pmol
1558 Parasitol Res (2009) 105:1557–1566RNA and from 0.45 to 1.2 nmol His-tagged DBL1α bound
to Ni-NTA agarose (Qiagen) in all cycles. A pre-selection
on 100µl Ni-NTA agarose was performed in every cycle
before incubation with DBL1α to avoid enrichment of
matrix binders. Incubation of RNA with DBL1α was
performed at 37°C with gentle agitation for 60 min in
starting cycles and decreased to 15 min in later cycles.
Beads were washed with 2×500µl PBSM (PBS, 1 mM
MgCl2) and RNA/protein eluted with 7 M UREA, 400 mM
imidazole, 50 mM NaH2PO4 (pH=7.4). The resulting
mixture was subjected to phenol/chloroform extraction for
eluting RNA aptamers from DBL1α. RNAwas precipitated
as previously described and ssDNA was generated by
adding primer B (5′-CGACTGCAGAGCTTGCTACG-3′)
in excess and 20 U of M-MuLV-RT (Fermentas) in supplied
buffer with 1 mM dNTP. 2′F-RNA was hydrolyzed in
0.1 M NaOH at 37°C for 30 min. ssDNAwas purified using
Ym-30 Microcon column. Oligo A was added in a 1:1 ratio
to the produced ssDNA. After annealing the two oligonu-
cleotides, dsDNA was created by Klenow fill out. The
dsDNA was amplified by polymerase chain reaction (PCR)
using Taq DNA polymerase (Fermentas) with a maximum
of 14 cycles using primer A (5′-GCGTAATACGACTCA
CTATAG-3′) and primer B. PCR product was pooled and
purified and used as template for next SELEX cycle. The
RNA recovery in each cycle was determined by measuring
the radioactivity of all collected fractions during the
experiment by diluting samples in 3 mL BetaMax ES
TM
Liquid Scintillation Fluid and recorded in a Beckman LS
3801 All DNA/RNA concentrations were determined with
NanoDrop
TM 1000 (Thermo Scientific).
Cloning and sequencing of RNA aptamers PCR amplified
dsDNA from SELEX pool 8 was cloned into TOPO vector
pCR
®4o rp C R
®2.1 (Invitrogen) and transformed into
E. coli strain Top10 (Invitrogen). Colonies were isolated
and insert was confirmed by Colony PCR with M13
primers. Positive clones were sequenced by AGOWA
(Germany). Sequences were aligned and screened for
conserved motifs using the MEME system motif discovery
search version 3.5.4 (Grundy et al. 1997).
Secondary RNA structure prediction Selected RNA mole-
cules were subjected to secondary structure prediction using
the Mfold software. The programme was run with defaults
settings listed on the updated homepage from the Institute
for Theoretical Chemistry at Vienna University. http://rna.
tbi.univie.ac.at/cgi-bin/RNAfold.cgi
Transcription of individual aptamers and their binding to
DBL1α
His Individual E. coli clones were grown in 5 ml
LB-amp (100µg/ml) at 37°C overnight. Plasmid was
isolated using mini-prep kit (Sigma). The template for T7
transcription was generated using primer A and primer B
for PCR. PCR product was purified by centrifugation on
MICROCON
® Ym-30 (Millipore). T7 transcription of
500 ng dsDNA template was performed in 20µl with
40 U T7 R&DNA™ polymerase, 1.25 mM 2′F-dUTP, 2′F-
dCTP (Epicentre) and ATP, GTP (Fermentas) and 10 mM
DTT, 0.37 Mbq [α-
32P]-ATP (Amersham Bioscience) at
37°C for 4 h. Template was digested using 1 U of DNAse at
37°C for 15 min. RNA was purified using MICROCON
®
ym-30. The RNA was mixed with PBSM and denatured at
95° for 3 min and stored at room temperature 15 min. Fifty-
nanomolar aptamers across different motifs were tested for
binding on 500 nM DBL1α
His bound to ~30µl Ni-NTA
agarose beads. Five hundred micrograms yeast RNA was
added and RNA was incubated with protein in PBSM for
45 min followed by four washes with 1 ml PBS and 0.05%
Triton x-100. Bound radioactive RNA was eluted with 7 M
UREA, 400 mM imidazole, 50 mM NaH2PO4 (pH=7.4)
and quantified with scintillator as previously described.
5′ end-labelling of aptamers and their binding to GST-
DBL1α Purified RNA aptamer, 0.5–1µg, was dephos-
phorylated with 1 U of shrimp alkaline phosphatase and
labelled with [γ-
32P]-ATP (Perkin Elmer) using T4 poly-
nucleotide kinase according to manufacturer’s instructions.
Forty nanograms labelled RNA (1.2 nM) and 1.2µg non-
labelled RNA (35.6 nM) was added to 20µl pre-coated
glutathione beads (~5–8µg GST-DBL1α) in 1.1 ml PBS
with 0.1% Triton x-100 and 300µg yeast RNA in
Eppendorf tube. Suspension incubated for 45 min with
rotation at room temperature. Beads washed three times
with 1 ml PBS with 0.1% Triton x-100. Bound radioactive
RNA was eluted with 50 mM Tris pH=8.0, 10 mM
glutathione and quantified as previously described. The
experiments were performed either twice or three times
with different protein and RNA batches. When standard
deviation is shown a two-tailed Student’s t test is performed
and significance is indicated in the figure.
Incubation of 5′ end-labelled aptamers with live culture of
FCR3S1.2 Three hundred nanograms (~10 nM) of 5′-
32P-
labelled RNA was incubated with 1 ml FCR3S1.2 culture
(5% parasitemia, 5% hematocrit) for 45 min at 37°C with
slow rotation. Cells were spun at 200×g and washed four
times with 1 ml PBS. Cell pellet was resuspended in 100µl
PBS and mixed with 3 ml scintillation fluid, vortexed, left
to settle and radioactivity was measured with scintillator.
The experiment was performed in triplicates on three
different occasions with different cell batches.
Rosetting disruption assay 2′F-RNA samples for disruption
assay were prepared as previous experiments. P. falciparum
strain FCR3S1.2 was cultured as previously described
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RNA samples to a finale volume of 100µl in concentrations
from 33 nM to 1µM. Unselected 2′F-RNA generated with
T7 transcription from unselected pool 0 was used as a
negative control. A reference culture with the addition of
the same volume of PBSM without 2′F-RNA was analysed
during the time course of the experiment to observe if there
was any change in the rosette rate during the experiment.
Parasites were incubated 1 h at room temperature with
gentle agitation. Culture was mixed with RPMI/acridine-
orange and analysed using UV-microscope for rosetting
status. Rosetting parasites were defined as infected eryth-
rocytes with two or more attached uninfected erythrocytes.
A minimum of 400 parasites were counted for each sample.
Upon auto-agglutination each individual parasite in a
cluster was counted as a rosetting parasite. Rosetting rate
was calculated as (rosetting parasites/(rosetting parasites+
non-rosetting parasites)×100). In the given experiment the
rosetting rate was correlated to the pool 0 control. The
experiments were performed at least three times for 4 and 8
µg/mL and twice at the other concentrations. Each
experiment was done on different occasions using different
2′F-RNA batches.
Results
Expression of DBL1α in E. coli The entire sequence of
DBL1α from FCR3S1.2 was optimised for the codon-usage
of E. coli to facilitate and increase the expression in the
bacteria (Flick et al. 2004). By His-tag high-affinity
purification soluble DBL1α
His was purified. Also a fusion
protein of glutathione S-transferase and DBL1α was
expressed in E. coli and purified with glutathione agarose
beads. Verification of the two recombinant proteins was
confirmed with immunoblots using DBL1α-specific anti-
bodies (data not shown). A previous study has confirmed
that the recombinant protein expressed in E. coli binds to
heparin in both free and bound form (Flick et al. 2004).
Selection of DBL1α-specific RNA aptamers For the in vitro
selection a combinatorial library of 5×10
14 unique RNA
sequences (Ellington and Szostak 1990; Tuerk and Gold
1990) was used. The strategy was to enrich for serum-stable
aptamers (Pieken et al. 1991) that would have affinity
towards the recombinant DBL1α domain from the high-
rosetting strain FCR3S1.2 (Chen et al. 2004). Eight rounds
of selection and amplification on DBL1α
His pre-bound to
nickel beads were performed. The course of the experiment
was monitored by determining the percentage of bound
RNA in every SELEX cycle (Fig. 1). Increasing recovery of
RNA was observed through the selection rounds and
maximum binding was achieved in cycle 8 with approxi-
mately 58% RNA recovery. The amplified DNA pool from
cycle 8 was cloned into the TOPO® TA vector, and the
nucleotide sequences of the randomised region of 85
individual clones were determined by sequencing (S 1).
Grouping of sequenced clones using MEME and testing of
individual aptamers on recombinant DBL1α
His Eighty-five
clones from the in vitro selection on recombinant DBL1
α
His were sequenced and analysed for conserved motifs
using the MEME software (Grundy et al. 1997). The
MEME software was set to discover a sequence of six to
seven conserved nucleotides in the dataset within the
randomised region from the 85 sequenced clones. Twenty
of the most common motifs are listed (S 2). In order to
characterise the different motifs, individual aptamers from
each different group were tested for binding on DBL1α
His.
The radioactive labelled aptamers were analysed and listed
according to their capacity to associate to the recombinant
protein (Fig. 2). The unselected pool 0 together with
aptamer c07 was found to have the lowest retention towards
DBL1α
His and b02, d12 and e05 the highest. These
aptamers were further tested in three individual binding
experiments (Fig. 2). Also the aptamers b02, d12 and e05
were detected in nine different motifs from the MEME data
and were chosen for further investigation (Table 1).
Theoretical structures of b02, d12 and e05 were achieved
using the Mfold software (Zuker 2003) and the structures
with the lowest free energies are depicted (Fig. 3). These
predicted structures indicate that the three aptamers have
different structures. Two isolated motifs in b02 are located
within two suggested adjacent stem/loop regions (Fig. 3,
b02). The motif AUCAA is suggested to be located in an
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Fig. 1 SELEX selection on recombinant DBL1α
His. A 2´-F substi-
tuted RNA library of 10
14 sequences was incubated with 0.45–1.3µM
recombinant DBL1α
His bound to Ni-NTA beads. 2′F-RNA was
internally labelled with
32P-[αATP] and the percentage of bound 2′
F-RNA recovery was quantified using scintillation count of obtained
fractions and listed for each of the eight selection rounds. White bars
represent pre-selection on the 100µl Ni-NTA matrix. Black bars are
selection on Ni-NTA with bound DBL1α
His
1560 Parasitol Res (2009) 105:1557–1566open loop structure found in b02, d12 and e05 (Fig. 3, b02,
d12 and e05). Three other motifs are found in e05. The
motif at position 21 is a part of a stem/loop. Two motifs at
55 and 69 are parts of a long transcending stem within the
RNA molecule (Fig. 3, e05).
Aptamer binding to GST-DBL1α To confirm that the
interaction of the aptamers with the protein was specific
an additional experiment was designed. Non-labelled RNA
was to compete with radioactive 5′-labelled RNA for
binding to a GST-DBL1α fusion protein. The recovery of
labelled RNA decreases 40% with the addition of 30-fold
molar excess of non-labelled RNA (Fig. 4). Furthermore,
the decrease is significant (P≤0.05). The two negative
controls in the experiment, unselected RNA (pool 0) and
e02, gave 85–90% lower recovery when compared to b02,
d12, e05 (P≤0.001).
To further confirm that the observed decrease is specific,
radioactive labelled d12 was incubated in the presence of
30-fold molar excess of e02 and pool 0 (Fig. 5). No
decrease was observed with the addition of RNA from
these two pools. In the experiment the observed decrease
upon competing labelled d12 with excess non-labelled d12
and the binding of d12 compared to e02 and pool 0 were
highly significant. This proposes that the decrease observed
is due to interaction between selected aptamers and its
target GST-DBL1α.
Aptamer binding to the surface of infected erythrocytes As
the selected aptamers were binding to the recombinant
DBL1α domain the next step was to verify if they could be
associated to the surface of the infected erythrocyte. Two of
these aptamers was compared to unselected RNA from pool
0 and the non-binding aptamer e02. Equal molar amounts
of RNA were end-labelled with
32P and incubated with 5%
parasitemia culture of FCR3S1.2. The results demonstrate
that the selected RNA is retained fourfold higher than RNA
from unselected pool or the non-binding aptamer e02
Table 1 Summary of groups identified using the MEME software containing b02, d12 and e05
St. P value Sites No.
b02 48 1.68e-04 CGCGT TTTTTCA AACAC 10
b02 35 3.37e-04 CACCA GCAATCA ACGCG 12
d12 60 2.86e-05 GCATC GAAGGTT GGCA 12
d12 53 2.80e-04 TTATC TTGCAT CGAAG 10
d12 24 8.58e-04 AAC AATACGA CTACA 10
d12
a 38 1.03e-03 ACACC ATCAAA AGTAT 10
e05
a 41 1.03e-03 AATGA ATCAAA AACAA 10
e05 21 3.07e-04 GTGACCA CGCGG 10
e05 69 7.96e-04 TTCGA CTACGC TAATT 10
e05 55 2.76e-05 AACAA CCAGGGC CGTTC 10
All groups contain 10 or more different aptamers. The start column (St.) indicates where in the aptamer, from the 5'-end, the conserved site start.
The P value is an estimate of the expected number of motifs with the given log-likelihood ratio (or higher), and with the same width and number
of occurrences, that one would find in a similarly sized set of random sequences. No. indicates the number of aptamers within the group
aSite found in both d12 and e05
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Fig. 2 Testing individual
aptamers on recombinant
DBL1α
His. Radioactive labelled
aptamers containing different
motifs were tested for binding
on DBL1α
His bound to Ni-NTA
agarose beads. Non-selected
RNA (Pool 0) is adjusted to the
value 1 and the recovery of
different aptamers is related to
this value. Clones are listed with
increasing recovery from left to
right. Clones b02, d12 and e05
are tested in triplicates. Error
bars present SDs
Parasitol Res (2009) 105:1557–1566 1561(Fig. 6). The difference between these two groups is highly
significant (P≤0.001).
Effects of RNA aptamers on rosetting in FCR3S1.2 in
vitro Since two of the selected aptamers showed significantly
higher association to the infected erythrocytes than unselected
RNA, the next step was to analyse whether this interaction
could affect the rosetting status of a blood culture of the highly
rosetting and multi-adhesive clone FCR3S1.2. The rosetting
and cytoadherence of FCR3S1.2 is sensitive to heparin and
heparansulphateandrosettescanbedisruptedwithanaddition
of 100µg/ml heparin (~7µM) in a 5% hematocrit culture with
5% parasitemia (Vogt et al. 2006). In a similar fashion we
investigated whether the SELEX-selected RNA aptamers
could disrupt the interaction between infected erythrocyte and
non-infected erythrocytes. The aptamers were tested in blood
cultures at a concentration of 1µg/ml (33 nM) to 12µg/ml
(387 nM), and with unselected RNA from pool 0 as a
negative control. A significant (P≤0.001) decrease in rosette
rate to 35% in relation to the control was observed at 8µg/ml
(258 nM) and a total disruption was seen at 12µg/ml for the
clones b02, d12 and e05 (Fig. 7a). Even though minimal
effect on rosette state was observed at a concentration of
33 nM, there was a clear visible effect when observing the
culture in the microscope as giant rosettes were decreased to
smaller rosettes. An example of rosette disruption can be seen
in the fluorescence image (Fig. 7b). The large rosettes which
are present in the sample treated with unselected RNA (Fig. 7
(B1)) are almost completely disrupted in the aptamer treated
sample (Fig. 7 (B2)). The infected erythrocytes are not
adhering to other infected or non-infected erythrocytes. RNA
from pool 0 did not disrupt rosettes in the concentration range
1–12µg/ml, but a small degree of disruption (5–10% lower
than untreated cells) was observed at an unselected RNA
concentration of 31µg/ml (1µM).
Discussion
It is generally accepted that severe malaria is most likely
caused by sequestration of the infected erythrocytes, yet
there is no specific anti-sequestration drug available today.
PfEMP1 is a key molecule used by P. falciparum to interact
with the human host in multiple ways (Flick and Chen
2004). The adhesive function of this protein makes it
possible for the parasite to adhere to endothelial lining and
uninfected erythrocytes. Disrupting PfEMP1/receptor inter-
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Fig. 4 Binding of
32P labelled
aptamers on GST-DBL1α. Ra-
dioactive labelled aptamer b02*,
d12*, e02* and e05* and unse-
lected RNA pool 0* were incu-
bated with GST-DBL1α bound
to glutathione beads. Labelled
RNA from binding aptamers
was competed with 30-fold ex-
cess non-labelled corresponding
RNA (b02, d12, e05). Bound
RNA* was quantified with
scintillator. Unit on y axis=
Bound RNA (mol). Error bars
present SDs. *P≤0.05 and
**P≤0.001, from a two-tailed
Student’s t test
Fig. 3 Mfold prediction on RNA structure from clones b02, d12 and e05. Structures represent predictions with low free energy. Nine motifs
isolated from the MEME search (S 2) are included. Location of the motif within the aptamer is shown with numbers listed from the 5′ end
1562 Parasitol Res (2009) 105:1557–1566actions using aptamers might be advantageous due to their
smaller size. This might give them greater potential to reach
more buried structures which antibodies are not able to
access due to steric hindrance. In addition, the RNA
aptamers are easy to chemically modify and elicit little or
no immunogenicity in therapeutic applications (Richardson
et al. 1999; Pendergrast et al. 2005). Furthermore, previous
work done with 2′F-modified RNA in serum demonstrate
the half-life of the RNA to be approximately 15 h (Lorger
et al. 2003). By SELEX technique aptamers were raised
against the semi-conserved DBL1α region of PfEMP1. In
this project we focused on generating RNA aptamers and
testing their binding capacity to recombinant DBL1α as
well as examining their capacity of rosette disruption. The
first step in a SELEX screening is to isolate the target for
selection. More complex and expensive systems such as a
cell-free-based system and baculovirus expression system
did not give better yields than our choice; E. coli. In all
systems protein solubility was limiting expression yields.
Through eight selection rounds on recombinant DBL1α
His
a major increase in specific RNA recovery was observed. To
identify conserved motifs among the selected RNA
aptamers, 85 clones were sequenced and analysed. The
outcome of the MEME search revealed 20 conserved groups
found within the 85 clones. The large variation among the
sequenced clones could be a result of the adherent nature of
DBL1α due to its overall positive charge giving rise to low
affinity interaction with RNA molecules. It is common to
increase selection pressure in later cycles by lowering the
protein concentration in relation to RNA concentration. Due
to the limited stability of the protein this was not performed.
Instead, shorter incubation times were chosen.
The initial screening of single clones on DBL1α
His
showed that selected RNA aptamers bind with higher
affinity than unselected RNA. The aptamers b02, d12 and
e05 gave up to fivefold higher recovery after incubation
with recombinant protein compared to unselected RNA
(Fig. 2). Later experiments with GST-DBL1α proved that
the binding was significant and specific since recovery of
the labelled aptamer could be decreased by adding an
excess of non-labelled RNA from b02, d12 and e05. No
decrease was observed by the addition of non-binding
aptamer e02 or pool 0, non-selected RNA. There is also a
similarity between the dose and response of these aptamers
(Fig. 7). This could be due to that they share the same
AUCAA motif found within loop regions in all three
aptamers (Fig. 3). In general the recovery rates were low in
relation to the estimated protein concentrations used in the
experiments. This could be due to the limited stability and
aggregation of the recombinant DBL1α. All work on the
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Fig. 5 Selective competition of
32P labelled d12 aptamer on
GST-DBL1α. Labelled aptamer
d12*, e02* and unselected RNA
pool 0* incubated with GST-
DBL1α bound on glutathione
beads. Thirty-fold non-labelled
RNA from d12, e02, and pool 0
was added. Bound labelled
RNA was quantified with scin-
tillator. Units on y axis=Bound
RNA (mol). Error bars present
SDs. **P≤0.001, from a two-
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Fig. 6 RNA association to the surface of FCR3S1.2 infected eryth-
rocytes. RNA, 9.8 pmol (10 nM), from clone d12, e05, e02 and pool 0
was incubated with 1 ml blood culture of FCR3S1.2. Cell pellet was
washedwith PBS. Bound labelledRNAfromresuspendedcell pellet was
measured with scintillator. Units on y axis=Bound RNA in mol. Error
bars present SDs, **P≤0.001, from a two-tailed Student’s t test
Parasitol Res (2009) 105:1557–1566 1563recombinant protein has no value, if aptamers do not bind
to the domain in its native environment (PfEMP1 on the
surface of the infected erythrocytes). The first approach to
verify biological relevance were to
32P-label the selected
aptamers and observe if they associate to the infected
erythrocyte to a higher degree than unselected RNA.
Selected RNA is retained significantly more on infected
erythrocytes than unselected RNA (Fig. 6). Binding levels
were generally low. We believe the limiting factor to be the
number of DBL1α binding sites in 1 ml parasite culture.
Even though no precise estimate of the number of PfEMP1
molecules per cell has been published, the number is
expected to be relatively low since detection by mass
spectrometry has failed (Ducret et al. 1998; Fried et al.
2004; Wu and Craig 2006).
Rosetting in FCR3S1.2 is likely to be due to the
interaction between DBL1α and heparan sulphate on the
non-infected erythrocyte since FCR3S1.2 is sensitive to
heparin (Chen et al. 2000). Rosetting strains which are less
sensitive to heparin might exploit other erythrocyte recep-
tors such as blood group A antigen (Barragan et al. 2000).
If the aptamers have a higher affinity towards DBL1α than
heparan sulphate, they might be able to compete with the
binding and thereby exclude and disrupt the HS/DBL1α
interaction, visualised by disrupted rosettes. This was tested
for the three SELEX selected clones b02, d12 and e05.
They were all able to disrupt rosettes in an in vitro culture
of FCR3S1.2 (Fig. 7a). A concentration as low as 33 nM
had an effect on the rosette status of the culture visualised
as a major decrease in size of the rosettes. Unselected RNA
did not have any effect at these concentrations. The selected
RNA has the ability to disrupt rosettes at 15 times lower
concentration than heparin in a similar experiment (Vogt et
al. 2006). Besides FCR3S1.2, the strain Dd2 was tested for
rosette disruption with similar results (data not shown).
The structures of the three aptamers were predicted using
the software for RNA folding. These given structures of the
aptamers are only theoretical and secondary characteriza-
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Fig. 7 Effect of 2′F-RNA of
selected SELEX clones on the
rosette state of FCR3S1.2.
a One hundred microlitres
aliquots of rosetting parasite
cultures (FCR3S1.2) were trea-
ted with 2′F-RNA at different
concentrations (1, 2, 4, 8, 10 and
12µg/ml). The rosetting rate was
counted after 1-h incubation and
compared with 2′F-RNA from
non-selected pool 0. Closed tri-
angle pool 0, open triangle e05,
open square b02, closed square
d12. Error bars present SDs. b
Rosette disruption of FCR3S1.2
visualised by fluorescence mi-
croscopy of cells stained with
acridine-orange with 400 times
magnification. Image B1 is con-
trol cells, which have been in-
cubated with non-selected 2′F-
RNA from pool 0 for 1 h. Image
B2 are cells treated 1 h with 10
µg/ml 2′F-RNA from SELEX
clone d12 (b)
1564 Parasitol Res (2009) 105:1557–1566tion of the RNA aptamers must be performed to verify the
secondary structure of the given RNA.
To summarise, the results show that DBL1α-specific
RNA aptamers have the potential to locate the protein on
the surface of infected erythrocytes. More importantly, the
aptamers can putatively be used as a novel anti-rosetting
drug. The next step will be to test the aptamers for rosette
disruption and sequestration of parasites in an animal model
to see if the aptamers are active in vivo (Moll et al. 2007).
Since the use of aptamers as putative therapeutic drugs is an
expanding field, knowledge on how to increase stability
and activity of aptamers in vivo is being generated as well
as decreasing the production cost. This will help in
facilitating future work in applying aptamers in vivo.
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